DiaMedica Therapeutics Inc. (DMAC) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 52.36M | 60.63M | 56.22M | 31.08M | 37.42M | 44.61M | 50.77M | 55.01M | 47.48M | 53.67M | 47.89M | 41.23M |
| Cash & Short-Term Investments | 51.33M | 59.89M | 55.32M | 30.04M | 36.32M | 44.15M | 50.2M | 54.05M | 46.52M | 52.9M | 46.47M | 40.37M |
| Cash Only | 4.87M | 15.65M | 3.33M | 4.11M | 2.59M | 3.02M | 4.13M | 14.07M | 2.1M | 4.54M | 2.23M | 5.84M |
| Short-Term Investments | 46.46M | 44.24M | 51.99M | 25.93M | 33.73M | 41.12M | 46.06M | 39.99M | 44.42M | 48.35M | 44.23M | 34.53M |
| Accounts Receivable | 0 | 258K | 260K | 161K | 253K | 236K | 290K | 391K | 399K | 369K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.03M | 481K | 645K | 680K | 649K | 227K | 280K | 568K | 569K | 0 | 1.02M | 247K |
| Total Non-Current Assets | 717K | 742K | 824K | 391K | 1.41M | 1.74M | 1.76M | 1.78M | 1.78M | 485K | 10.25M | 20.82M |
| Property, Plant & Equipment | 317K | 342K | 368K | 391K | 408K | 427K | 449K | 469K | 468K | 485K | 507K | 523K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 | 0 | 0 | 9.75M | 20.3M |
| Other Non-Current Assets | 400K | 400K | 456K | 0 | 0 | 1.31M | 1.31M | 1.31M | 1.31M | 0 | 0 | 0 |
| Total Assets | 53.08M | 61.37M | 57.05M | 31.47M | 38.83M | 46.34M | 52.52M | 56.79M | 49.26M | 54.16M | 58.14M | 62.05M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 36.7% | 32.42% | 8.61% | -44.59% | -21.17% | -14.43% | -9.66% | -8.48% | 63.02% | 57.46% | 56.96% | 58.06% |
| Total Current Liabilities | 5.75M | 5.13M | 5.27M | 4.12M | 4.67M | 5.39M | 4.3M | 3.09M | 2.62M | 2.79M | 2.17M | 1.95M |
| Accounts Payable | 3.29M | 1.48M | 1.92M | 1.26M | 1.51M | 940K | 1.17M | 759K | 716K | 926K | 863K | 856K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 115K | 112K | 109K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.34M | 3.54M | 2.32M | 590K | 341K | 1.06M | 730K | 473K | 317K | 766K | 0 | 0 |
| Current Ratio | 9.11x | 11.81x | 10.67x | 7.55x | 8.02x | 8.28x | 11.81x | 17.82x | 18.14x | 19.27x | 22.07x | 21.19x |
| Quick Ratio | 9.11x | 11.81x | 10.67x | 7.55x | 8.02x | 8.28x | 11.81x | 17.82x | 18.14x | 19.27x | 22.07x | 21.19x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 97K | 128K | 157K | 184K | 211K | 237K | 263K | 288K | 294K | 317K | 340K | 361K |
| Long-Term Debt | 97K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 128K | 157K | 184K | 211K | 237K | 263K | 288K | 294K | 317K | 340K | 361K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.84M | 5.26M | 5.42M | 4.3M | 4.88M | 5.63M | 4.56M | 3.38M | 2.91M | 3.1M | 2.51M | 2.31M |
| Total Debt | 212K | 240K | 266K | 292K | 316K | 340K | 365K | 388K | 380K | 400K | 420K | 440K |
| Net Debt | -4.66M | -15.41M | -3.06M | -3.82M | -2.27M | -2.69M | -3.77M | -13.68M | -1.72M | -4.14M | -1.81M | -5.4M |
| Debt / Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 47.23M | 56.11M | 51.62M | 27.17M | 33.95M | 40.72M | 47.96M | 53.41M | 46.35M | 51.06M | 55.63M | 59.74M |
| Equity Growth % | 39.11% | 37.8% | 7.63% | -49.13% | -26.74% | -20.25% | -13.78% | -10.59% | 71.52% | 60.42% | 58.58% | 58.41% |
| Book Value per Share | 0.88 | 1.19 | 1.04 | 0.63 | 0.79 | 0.95 | 1.12 | 1.40 | 1.22 | 1.35 | 1.47 | 2.19 |
| Total Shareholders' Equity | 47.23M | 56.11M | 51.62M | 27.17M | 33.95M | 40.72M | 47.96M | 53.41M | 46.35M | 51.06M | 55.63M | 59.74M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -182.81M | -172.77M | -164.03M | -155.41M | -147.71M | -140M | -132.1M | -125.83M | -120.71M | -115.56M | -110.4M | -105.93M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -26K | 50K | 50K | -14K | 5K | 23K | 81K | -51K | -39K | 6K | -127K | -63K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |